Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy

Study ID: NCT06120829
Start Date: 2023-12
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

490

Intervention / Treatment

Cryobiopsy

Cryobiopsy

Core Needle Biopsy

Sponsor

San Antonio Uniformed Services Health Education Consortium

Source: clinicaltrials.gov

Share:
Add to list

A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

Study ID: NCT06630429
Start Date: 2020-09-02
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Biospecimen Collection

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Study ID: NCT05785780
Start Date: 2022-11-01
End Date: 2025-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Targeted CRC Screening Toolkit

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of FMISO in Brain Tumors

Study ID: NCT03649880
Start Date: 2019-06-01
End Date: 2030-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

¹⁸F-Fluoromisonidazole

Computed Tomography

Magnetic Resonance Imaging

Positron Emission Tomography

Oxygen Therapy

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

Study ID: NCT03964480
Start Date: 2018-10-14
End Date: 2025-07-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

Angela Serra Association for Cancer Research

Source: clinicaltrials.gov

Share:
Add to list

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Study ID: NCT06635980
Start Date: 2025-06-20
End Date: 2034-10-21
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Biopsy of Breast

Biospecimen Collection

Breast Surgery

Chemotherapy

Computed Tomography

Contrast Enhanced Digital Mammography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

Positron Emission Tomography

Survey Administration

Tissue Collection

Ultrasound Imaging

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Study ID: NCT05438329
Start Date: 2022-07-19
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

1123

Intervention / Treatment

DB-1305/BNT325

Pembrolizumab

Benah

Sponsor

DualityBio Inc.

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Study ID: NCT05440929
Start Date: 2022-07-15
End Date: 2025-07-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Clinician Qualitative Interview

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Cancer Biospecimen Collection Study

Study ID: NCT04510129
Start Date: 2020-02-05
End Date: 2027-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1650

Intervention / Treatment

OncoPrism™ assay

Sponsor

Cofactor Genomics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Study ID: NCT05544929
Start Date: 2022-10-26
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

180

Intervention / Treatment

KFA115

pembrolizumab

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list